American journal of therapeutics最新文献

筛选
英文 中文
Evaluating Safety of Morphine Sulfate Use in Noncritically Ill Patients With Acute Kidney Injury in the Hospital Setting. 评估医院环境中急性肾损伤非危重病人使用硫酸吗啡的安全性。
IF 2.9 4区 医学
American journal of therapeutics Pub Date : 2024-09-01 DOI: 10.1097/MJT.0000000000001733
Courtney Mackzum, Ronda Ambroziak, Chanda Mullen, Jenna Garlock
{"title":"Evaluating Safety of Morphine Sulfate Use in Noncritically Ill Patients With Acute Kidney Injury in the Hospital Setting.","authors":"Courtney Mackzum, Ronda Ambroziak, Chanda Mullen, Jenna Garlock","doi":"10.1097/MJT.0000000000001733","DOIUrl":"https://doi.org/10.1097/MJT.0000000000001733","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":"31 5","pages":"e580-e584"},"PeriodicalIF":2.9,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142279229","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Low-Dose Methylphenidate Treatment for Apathy After Traumatic Brain Injury. 小剂量哌醋甲酯治疗创伤性脑损伤后的冷漠症。
IF 2.9 4区 医学
American journal of therapeutics Pub Date : 2024-09-01 DOI: 10.1097/MJT.0000000000001672
Shun-Hsing Tuan, Chih-Ya Chang, Ta-Chuan Yeh, Nian-Sheng Tzeng
{"title":"Low-Dose Methylphenidate Treatment for Apathy After Traumatic Brain Injury.","authors":"Shun-Hsing Tuan, Chih-Ya Chang, Ta-Chuan Yeh, Nian-Sheng Tzeng","doi":"10.1097/MJT.0000000000001672","DOIUrl":"https://doi.org/10.1097/MJT.0000000000001672","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":"31 5","pages":"e552-e555"},"PeriodicalIF":2.9,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142279235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and Safety of Interleukin-12/23 and Interleukin-23 Inhibitors for Ulcerative Colitis: A Systematic Review Ad Meta-Analysis of Randomized Controlled Trials. 白细胞介素-12/23 和白细胞介素-23 抑制剂治疗溃疡性结肠炎的有效性和安全性:随机对照试验的系统综述和元分析》。
IF 2.9 4区 医学
American journal of therapeutics Pub Date : 2024-08-30 DOI: 10.1097/MJT.0000000000001766
Fouad Jaber, Mohammed Ayyad, Saqr Alsakarneh, Tala Alsharaeh, Ahmed-Jordan Salahat, Mohammad Jaber, Manesh Kumar Gangwani, Yazan Abboud, Islam Mohamed, Hassam Ali, Yassine Kilani, Francis A Farraye, Jana G Hashash
{"title":"Efficacy and Safety of Interleukin-12/23 and Interleukin-23 Inhibitors for Ulcerative Colitis: A Systematic Review Ad Meta-Analysis of Randomized Controlled Trials.","authors":"Fouad Jaber, Mohammed Ayyad, Saqr Alsakarneh, Tala Alsharaeh, Ahmed-Jordan Salahat, Mohammad Jaber, Manesh Kumar Gangwani, Yazan Abboud, Islam Mohamed, Hassam Ali, Yassine Kilani, Francis A Farraye, Jana G Hashash","doi":"10.1097/MJT.0000000000001766","DOIUrl":"https://doi.org/10.1097/MJT.0000000000001766","url":null,"abstract":"<p><strong>Background: </strong>Targeting interleukin-23 (IL-23) represents a significant therapeutic avenue for treating ulcerative colitis (UC).</p><p><strong>Study question: </strong>What are the effectiveness and safety of selective inhibitors targeting IL-23p19 and IL-12/23p40 in individuals with moderate-to-severe UC?</p><p><strong>Data sources: </strong>MEDLINE, Embase, Scopus, and Cochrane databases.</p><p><strong>Study design: </strong>A systematic search of MEDLINE, Embase, Scopus, and Cochrane databases till January 15, 2024, to identify randomized controlled trials comparing IL-23p19 and IL-12/23p40 inhibitors against placebo or active comparators in UC patients. The primary outcome was clinical remission, with secondary outcomes including clinical response, endoscopic remission, and safety profiles during induction and maintenance phases. Using a fixed-effect model, we pooled dichotomous data with risk ratio (RR) and 95% confidence interval (CI) for analysis.</p><p><strong>Results: </strong>In 5 trials involving 1120 patients with moderate to severe UC, targeting IL-23 showed significant superiority in inducing clinical remission [RR: 2.08, 95% CI, (1.66-2.61)], endoscopic remission [RR: 1.73, 95% CI, (1.39-2.16)], and histologic remission [RR: 1.88, 95% CI, (1.34-2.64)]. Additionally, individuals treated with IL-12/23p40 or IL-23p19 antagonists maintained clinical remission [RR: 1.85, 95% CI, (1.53-2.23)], endoscopic remission [RR: 2.03, 95% CI, (1.60-2.57)], and histologic remission [RR: 1.66, 95% CI, (1.11-2.48)]. Targeting IL-23 was linked with a reduced risk of any adverse events (AE) during both induction [RR: 0.94, 95% CI, (0.86-1.02)] and maintenance phases [RR: 0.93, 95% CI, (0.86-0.99)], any serious AE during the induction phase [RR: 0.53, 95% CI, (0.36-0.78)], and withdrawal due to AEs compared to patients receiving placebo during induction [RR: 0.24, 95% CI (0.14, 0.43)].</p><p><strong>Conclusion: </strong>Targeting IL-23 demonstrates efficacy and safety for inducing and maintaining clinical and endoscopic remission in moderate-to-severe UC patients.</p>","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142103615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rivaroxaban-Associated Neutropenia. 利伐沙班相关性中性粒细胞减少症。
IF 2.9 4区 医学
American journal of therapeutics Pub Date : 2024-08-28 DOI: 10.1097/MJT.0000000000001817
Zimeng Wan, Xiaohong Liu
{"title":"Rivaroxaban-Associated Neutropenia.","authors":"Zimeng Wan, Xiaohong Liu","doi":"10.1097/MJT.0000000000001817","DOIUrl":"https://doi.org/10.1097/MJT.0000000000001817","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2024-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142085882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Attitudes and Knowledge of Medical Students in South of Israel Toward Medical Cannabis. 以色列南部医科学生对医用大麻的态度和认识。
IF 2.9 4区 医学
American journal of therapeutics Pub Date : 2024-08-28 DOI: 10.1097/MJT.0000000000001821
Richard Isralowitz, Patricia A Findley, Alexander Reznik
{"title":"Attitudes and Knowledge of Medical Students in South of Israel Toward Medical Cannabis.","authors":"Richard Isralowitz, Patricia A Findley, Alexander Reznik","doi":"10.1097/MJT.0000000000001821","DOIUrl":"https://doi.org/10.1097/MJT.0000000000001821","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2024-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142103614","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transthyretin Stabilizers Treatment in Patients With Transthyretin-Mediated Cardiac Amyloidosis: A Systematic Review and Meta-Analysis. 转甲状腺素稳定剂治疗转甲状腺素介导的心脏淀粉样变性患者:系统回顾与元分析》。
IF 2.9 4区 医学
American journal of therapeutics Pub Date : 2024-08-27 DOI: 10.1097/MJT.0000000000001799
Mohammad Tanashat, Osama Bisht, Mohamed Abuelazm, Obieda Altobaishat, Ubaid Khan, Mohamed Abouzid
{"title":"Transthyretin Stabilizers Treatment in Patients With Transthyretin-Mediated Cardiac Amyloidosis: A Systematic Review and Meta-Analysis.","authors":"Mohammad Tanashat, Osama Bisht, Mohamed Abuelazm, Obieda Altobaishat, Ubaid Khan, Mohamed Abouzid","doi":"10.1097/MJT.0000000000001799","DOIUrl":"https://doi.org/10.1097/MJT.0000000000001799","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142078836","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Short-Term Primary Rifaximin Prophylaxis Has No Beneficial Role in Patients With Cirrhosis. 短期利福昔明预防性治疗对肝硬化患者无益处
IF 2.9 4区 医学
American journal of therapeutics Pub Date : 2024-08-27 DOI: 10.1097/MJT.0000000000001802
Sai Spoorthy Penumarthi, Bhavani Lalkota, Shivani Jangili, Shruthi Salla, Santhosh Reddy Satti, Shantan Venishetty, Manasa Alla, Sowmya Iyengar, Mithun Sharma, P N Rao, D Nageshwar Reddy, Anand V Kulkarni
{"title":"Short-Term Primary Rifaximin Prophylaxis Has No Beneficial Role in Patients With Cirrhosis.","authors":"Sai Spoorthy Penumarthi, Bhavani Lalkota, Shivani Jangili, Shruthi Salla, Santhosh Reddy Satti, Shantan Venishetty, Manasa Alla, Sowmya Iyengar, Mithun Sharma, P N Rao, D Nageshwar Reddy, Anand V Kulkarni","doi":"10.1097/MJT.0000000000001802","DOIUrl":"https://doi.org/10.1097/MJT.0000000000001802","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142078835","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of L-PGDS Suppression on Cerebral Ischemia/Reperfusion Injury Through the PPARγ/AMPK/mTOR Pathway: Clinical Implications for Therapeutic Intervention. 通过 PPARγ/AMPK/mTOR 通路抑制 L-PGDS 对脑缺血再灌注损伤的影响:治疗干预的临床意义》。
IF 2.9 4区 医学
American journal of therapeutics Pub Date : 2024-08-22 DOI: 10.1097/MJT.0000000000001801
Li Li, Yong-Ping Chen, Ya He, Min Wang, Sheng-Li Chen, Li-Na Zhang
{"title":"Impact of L-PGDS Suppression on Cerebral Ischemia/Reperfusion Injury Through the PPARγ/AMPK/mTOR Pathway: Clinical Implications for Therapeutic Intervention.","authors":"Li Li, Yong-Ping Chen, Ya He, Min Wang, Sheng-Li Chen, Li-Na Zhang","doi":"10.1097/MJT.0000000000001801","DOIUrl":"https://doi.org/10.1097/MJT.0000000000001801","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142035025","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to Mitapivat: A Quinolone Sulfonamide to Manage Hemolytic Anemia in Adults With Pyruvate Kinase Deficiency. 对 Mitapivat:一种用于治疗丙酮酸激酶缺乏症成人溶血性贫血的喹诺酮磺酰胺。
IF 2.9 4区 医学
American journal of therapeutics Pub Date : 2024-08-21 DOI: 10.1097/MJT.0000000000001786
Audra Boscoe, Rebecca McCracken, Punit Marathe, Kareem Osman
{"title":"Response to Mitapivat: A Quinolone Sulfonamide to Manage Hemolytic Anemia in Adults With Pyruvate Kinase Deficiency.","authors":"Audra Boscoe, Rebecca McCracken, Punit Marathe, Kareem Osman","doi":"10.1097/MJT.0000000000001786","DOIUrl":"https://doi.org/10.1097/MJT.0000000000001786","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2024-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142016148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparing Intravenous Dexmedetomidine With Midazolam in Patients Undergoing Bronchoscopy: A Meta-analysis of Randomized Controlled Trials. 对接受支气管镜检查的患者进行右美托咪定与咪达唑仑的静脉注射比较:随机对照试验的 Meta 分析。
IF 2.9 4区 医学
American journal of therapeutics Pub Date : 2024-08-21 DOI: 10.1097/MJT.0000000000001818
Yujie Liang, Wenxing Xu, Weijie He
{"title":"Comparing Intravenous Dexmedetomidine With Midazolam in Patients Undergoing Bronchoscopy: A Meta-analysis of Randomized Controlled Trials.","authors":"Yujie Liang, Wenxing Xu, Weijie He","doi":"10.1097/MJT.0000000000001818","DOIUrl":"https://doi.org/10.1097/MJT.0000000000001818","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2024-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142016146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信